Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Oncology
|
June 1, 2022
Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors
Peng Gu, Liting Xue, Chunyan Zhao, et al.
Blood
|
May 23, 2012
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling
John Anto Pulikkan, Dmitri Madera, Liting Xue, et al.
Molecular Cancer Therapeutics
|
April 21, 2026
PRMT5 Inhibition by SCR-6920 Downregulates HIF-1α and Exhibits Synergistic Antitumor Activity with Bevacizumab in Ovarian Cancer
Guimei Yang, Huixia Dou, Liting Xue, et al.
Molecular Cancer Therapeutics
|
April 21, 2026
PRMT5 inhibition by SCR-6920 downregulates HIF-1α and exhibits synergistic antitumor activity with bevacizumab in ovarian cancer
Guimei Yang, Huixia Dou, Liting Xue, et al.
Medcomm
|
September 23, 2024
SCR-7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the <i>S</i>-adenosylmethionine-competitive or the methylthioadenosine-cooperative protein arginine methyltransferase 5 inhibitors in methylthioadenosine phosphorylase-deleted tumors
Zhiyong Yu, Yi Kuang, Liting Xue, et al.
International Immunopharmacology
|
July 21, 2024
Technical considerations and strategies for generating and optimizing humanized mouse tumor models in immuno-oncology research
Wenjing Li, Chunlei Xia, Kun Wang, et al.
Science Translational Medicine
|
September 5, 2014
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
Leyuan Ma, Yi Shan, Robert Bai, et al.
Science (New York, N.Y.)
|
February 14, 2015
Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice
Anuradha Illendula, John A Pulikkan, Hongliang Zong, et al.
Journal of Medicinal Chemistry
|
December 30, 2025
Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy
Wei Zhu, Lei Jiang, Dongxing Zhu, et al.
Journal of Neurology
|
February 7, 2026
JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model
Jialu Zhao, Siqi Ge, Shujun Gao, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Frontiers in Oncology
|
June 1, 2022
Targeting the Homologous Recombination Pathway in Cancer With a Novel Class of RAD51 Inhibitors
Peng Gu, Liting Xue, Chunyan Zhao, et al.
Blood
|
May 23, 2012
Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling
John Anto Pulikkan, Dmitri Madera, Liting Xue, et al.
Molecular Cancer Therapeutics
|
April 21, 2026
PRMT5 Inhibition by SCR-6920 Downregulates HIF-1α and Exhibits Synergistic Antitumor Activity with Bevacizumab in Ovarian Cancer
Guimei Yang, Huixia Dou, Liting Xue, et al.
Molecular Cancer Therapeutics
|
April 21, 2026
PRMT5 inhibition by SCR-6920 downregulates HIF-1α and exhibits synergistic antitumor activity with bevacizumab in ovarian cancer
Guimei Yang, Huixia Dou, Liting Xue, et al.
Medcomm
|
September 23, 2024
SCR-7952, a highly selective MAT2A inhibitor, demonstrates synergistic antitumor activities in combination with the <i>S</i>-adenosylmethionine-competitive or the methylthioadenosine-cooperative protein arginine methyltransferase 5 inhibitors in methylthioadenosine phosphorylase-deleted tumors
Zhiyong Yu, Yi Kuang, Liting Xue, et al.
International Immunopharmacology
|
July 21, 2024
Technical considerations and strategies for generating and optimizing humanized mouse tumor models in immuno-oncology research
Wenjing Li, Chunlei Xia, Kun Wang, et al.
Science Translational Medicine
|
September 5, 2014
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia
Leyuan Ma, Yi Shan, Robert Bai, et al.
Science (New York, N.Y.)
|
February 14, 2015
Chemical biology. A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice
Anuradha Illendula, John A Pulikkan, Hongliang Zong, et al.
Journal of Medicinal Chemistry
|
December 30, 2025
Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy
Wei Zhu, Lei Jiang, Dongxing Zhu, et al.
Journal of Neurology
|
February 7, 2026
JAK2 pathogenic variants in ischemic stroke: low prevalence and pre-screening model
Jialu Zhao, Siqi Ge, Shujun Gao, et al.
Page
of 2